secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2022-11-21T23:59:59+00:00
Accession:  0001104659-22-120486
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora raises $3.12M by reducing Class A warrant exercise price to $4.77, issuing new warrants
--------------------------------------------------------------------------------

- Gross proceeds of $3.12 million from immediate cash exercise of 654,609 Class A warrants.
- Exercise price of Class A warrants reduced from $8.00 to $4.77 per share.
- New Inducement Warrants issued at $5.97 per share, exercisable after 6 months, term 18 months.
- Ladenburg Thalmann acted as exclusive placement agent, receiving 8% of gross proceeds.
- New warrants and underlying shares are unregistered, issued in a private placement under Section 4(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000110465922120486/0001104659-22-120486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000110465922120486/tm2230976d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-120486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer